BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 9016418)

  • 1. Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
    Beyth RJ; Antani MR; Covinsky KE; Miller DG; Chren MM; Quinn LM; Landefeld CS
    J Gen Intern Med; 1996 Dec; 11(12):721-8. PubMed ID: 9016418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation.
    Antani MR; Beyth RJ; Covinsky KE; Anderson PA; Miller DG; Cebul RD; Quinn LM; Landefeld CS
    J Gen Intern Med; 1996 Dec; 11(12):713-20. PubMed ID: 9016417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey.
    Gross CP; Vogel EW; Dhond AJ; Marple CB; Edwards RA; Hauch O; Demers EA; Ezekowitz M
    Clin Ther; 2003 Jun; 25(6):1750-64. PubMed ID: 12860496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.
    Choudhry NK; Anderson GM; Laupacis A; Ross-Degnan D; Normand SL; Soumerai SB
    BMJ; 2006 Jan; 332(7534):141-5. PubMed ID: 16403771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.
    Matchar DB; Samsa GP; Cohen SJ
    J Gen Intern Med; 1996 Dec; 11(12):768-70. PubMed ID: 9016428
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent national patterns of warfarin use in atrial fibrillation.
    Stafford RS; Singer DE
    Circulation; 1998 Apr; 97(13):1231-3. PubMed ID: 9570191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China.
    Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y;
    Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners.
    Monette J; Gurwitz JH; Rochon PA; Avorn J
    J Am Geriatr Soc; 1997 Sep; 45(9):1060-5. PubMed ID: 9288012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in atrial fibrillation. Does efficacy in clinical trials translate into effectiveness in practice?
    Gottlieb LK; Salem-Schatz S
    Arch Intern Med; 1994 Sep; 154(17):1945-53. PubMed ID: 8074598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' attitudes toward anticoagulant therapy in patients with chronic atrial fibrillation.
    Maeda K; Sakai T; Hira K; Sato TS; Bito S; Asai A; Hayano K; Matsumura S; Yamashiro S; Fukui T
    Intern Med; 2004 Jul; 43(7):553-60. PubMed ID: 15335179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
    Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
    Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of warfarin use in patients with atrial fibrillation at low or intermediate risk and relation to thromboembolic events.
    Chae SH; Froehlich J; Morady F; Oral H
    Clin Cardiol; 2011 Oct; 34(10):640-4. PubMed ID: 21994084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician practices regarding anticoagulation and cardioversion of atrial fibrillation.
    Schlicht JR; Davis RC; Naqi K; Cooper W; Rao BV
    Arch Intern Med; 1996 Feb; 156(3):290-4. PubMed ID: 8572839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review.
    Pugh D; Pugh J; Mead GE
    Age Ageing; 2011 Nov; 40(6):675-83. PubMed ID: 21821732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
    Kutner M; Nixon G; Silverstone F
    Arch Intern Med; 1991 Oct; 151(10):1950-3. PubMed ID: 1929682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention.
    Peterson GM; Boom K; Jackson SL; Vial JH
    Intern Med J; 2002; 32(1-2):15-23. PubMed ID: 11783668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin for atrial fibrillation. The patient's perspective.
    Man-Son-Hing M; Laupacis A; O'Connor A; Wells G; Lemelin J; Wood W; Dermer M
    Arch Intern Med; 1996 Sep; 156(16):1841-8. PubMed ID: 8790079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
    Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
    N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in atrial fibrillation.
    Turpie AG; Connolly SJ
    Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.